BenzingaOctober 20, 2026 at 7:30 AM NY7 Days Ago
Canaccord Genuity Maintains Buy on Fractyl Health, Lowers Price Target to $39
Canaccord Genuity analyst Whitney Ijem maintains Fractyl Health (NASDAQ:GUTS) with a Buy and lowers the price target from $96 to $39.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
